Patent · US Active

Methods and agents that enhance myogenic progenitor cell engraftment

US11534418B2 · kind B2 · utility

1Cited by
0References
11Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJul 16, 2020
Grant dateDec 27, 2022
Priority date—
Expiry dateJul 16, 2040

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2501/999
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed herein are agents that enhance muscle stem cell engraftment, as well as methods and compositions using the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.